An Investigation for the Mobility of Fibrinolysis System During the Cardiosurgery Extracorporeal Circulation Period

JIANG Hong,CHEN Chuan,JIA Jin,ZHOU Jing,HAN Shuai,LIAO Juan,WANG Xia
DOI: https://doi.org/10.3969/j.issn.1009-6213.2007.05.008
2007-01-01
Abstract:Objective To find the mobility rule of fibrinolysis system for patient during the cardiosurgery extracorporeal circulation period in order for the drug-monitoring to based on .Methods 79 valve replacement patient were divided into two groups according to the antifibrinolytic agent they used. D-dimer、α2-AP were analyzed before the operation、aorta opened during the operation, and 72 hr after the surgery .Results (1) Transversal comparison: for patient use 6-aminohexanoic acid and aprotinin, before the operation , for both D-dimer and α2-AP ,the difference between two groups have no statistics discrepancy, P0.05; while aorta opened during the operation, there is statistics discrepancy, P0.05; 72 h after the surgery , the difference between two groups have no statistics discrepancy, P0.05。(2)Comparison:for both 6-aminohexanoic acid and aprotinin groups, D-dimer and α2-AP have no statistics discrepancy, P0.05, but there is statistics discrepancy for D-dimmer before and during the operation, and there is also statistics discrepancy for D-dimmer during and after the operation.Conclusion (1) From the comparison , there is significant variation, which indicate the alteration of fibrinolysis system, so ,it should be close monitored.(2) From the transversal comparison, it indicate there is differential between these two anti-fibrinolysis therapy during the operation, while after the operation, there is not.
What problem does this paper attempt to address?